GLOBAL GOLD NANOPARTICLES MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL GOLD NANOPARTICLES MARKET FORECAST 2019-2027

GLOBAL GOLD NANOPARTICLES MARKET FORECAST 2019-2027

Nanoparticles are microscopic particles that exist on a nanometer (nm) scale [i.e., below 100 nm in at least one dimension]. They can possess physical properties such as uniformity, conductance or special optical properties that are favorable in materials science and biology. Gold nanoparticles are nothing but nanoparticles of gold which have a variety of applications. Global gold nanoparticle market is estimated to grow with 16.90% CAGR during the year 2019 – 2027. 

GLOBAL GOLD NANOPARTICLES MARKET FORECAST 2019-2027

Global Gold Nanoparticles Market by Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro Assays, Cell & Phantom Imaging and Other Applications), by End-use (Healthcare, Electronics, Catalytic Activity and Other End-use) and Geography.

Request free sample

Nanoparticles are microscopic particles that exist on a nanometer (nm) scale [i.e., below 100 nm in at least one dimension]. They can possess physical properties such as uniformity, conductance or special optical properties that are favorable in materials science and biology. Gold nanoparticles are nothing but nanoparticles of gold which have a variety of applications. Global gold nanoparticle market is estimated to grow with 16.90% CAGR during the year 2019 – 2027.  The base year considered for the study is 2018 and the estimated period is between 2019 and 2027. The following factors drive the growth of this market:

  • Higher demand from developing economies
  • Preference for compact electronic devices
  • Development of ultra-light materials

The most important driver is their demand from the developing countries. The global gold nanoparticles market is witnessing an increase in demand from developing economies due to their improved economic scenario, including a rise in the per capita income of people. There is a high demand for end-use applications in healthcare, electronics, cosmetics and photometry, in line with the increasing per capita income in developing economies. Gold nanoparticles’ optical and conduction properties make their use irreplaceable in the electronic items produced by the industries in the developing nations. Nanoparticles are also used in the field of medical diagnostics, drug delivery systems, and cancer and tumor cell detection.

The largest application for this particular market lies in its targeted drug delivery segment. The concept of targeted drugs is not modern, but it dates back to 1906 when Dr Paul Ehrlich first postulated the ‘magic bullet’. The ability to withstand the test of time of this concept is a strong indication of its appeal, but the ‘magic bullet’ remains to be a challenge to implement in the clinic. Target drug delivery system is a special form of drug delivery system where the pharmacologically active agent or medication drug is selectively targeted or delivered by the nanoparticles only to the corresponding site of action or absorption, and not to the non-target organs or tissues or cells. Introducing nanoparticles in the system brings benefits such as high targeting efficiency, high therapeutic efficacy and reproducibility. Gold nanoparticles (GNPs) are recommended in such system for the further API and antibody functionalization.  There are two types of drug targeting, passive targeting and active targeting. Passive targeting refers to the accumulation of the drug or drug-carrier system at a particular site due to physicochemical or pharmacological factors, while the active targeting employs a specific modification of drug/drug carrier nanosystems with active agents having selective affinity for recognizing and interacting with a specific cell, tissue or organ in the body. Active targeting can be further divided into three orders.

The restraints and challenges of gold nanoparticle market are the biocompatibility of gold nanoparticles, unpredictable gold prices and high average prices. Among them, the major restraint faced by the gold nanoparticles market is the biocompatibility of gold. There has been continuous improvement in the methods employed to ensure that the gold nanoparticles become biocompatible. This helps produce toxic-free and eco-friendly products based on gold nanoparticles. Some research has been conducted by the companies involved in the business of gold nanoparticles. The developments in this field will provide a way to resolve one of the key hindrances in the gold nanoparticles market. Green chemistry is extensively being used in studies around the globe to formulate biocompatible gold nanoparticles through eco-friendly methods. This is expected to open many doors for opportunities to market players. The “nanoComposix” has developed a technology for the biosynthesis of nanoparticles. Various nanobiotechnology companies are anticipated to develop innovative and eco-friendly methods for the synthesis of gold nanoparticles.

The report on global gold nanoparticle market includes segmentation on the basis of end use and application.

End use type is sub-segmented into:

  • Healthcare
  • Electronics
  • Catalytic Activity
  • Others

Application type is sub-segmented into:

  • In-vivo Imaging
  • Targeted Drug Delivery
  • Proton Therapy
  • In-vitro Assays
  • Cell & Phantom Imaging
  • Others

Geographically, the global gold nanoparticle control system market has been segmented on the basis of four major regions, which includes:

  • North America: the United States & Canada.
  • Europe: Germany, the United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Asia Pacific: China, India, Japan, South Korea, Australia, Rest of Asia Pacific.
  • Rest of World: Latin America, Middle East & Africa.

North America has the largest market for gold nanoparticle market. The increase in the usage of gold nanoparticles in various applications, for instance, in the enlarging industries that manufacture products that chiefly use photovoltaic cells and optics, are driving the market growth in North America. The market is witnessing robust growth in terms of revenue; primarily due to the size of the healthcare sector in the US, which is valued to be $ X trillion — the largest in the world. The higher spending on healthcare is expected to result in more investment in R&D related to gold nanoparticles, leading to their increased consumption. In the United States alone, more than six billion dollars have been invested in nanotechnology research and more than sixty centers, networks, and facilities, funded by various agencies, are in operation or are opening soon. After establishing an interdisciplinary nanotechnology workforce, it is expected that nanotechnology will mature into a clinically useful field shortly. One of the major applications of nanotechnology is in biomedicine. Nanoparticles can be engineered as ‘nanoplatforms’ for effective and targeted delivery of drugs and imaging labels by overcoming the many biological, biophysical and biomedical barriers.

The major market players of the global gold nanoparticle market are:

  • Agilent Technologies, Inc.
  • BBI solutions
  • Cline Scientific
  • Cytodiagnostics
  • Meliorum Technologies
  • Others

Company profiles cover analysis of important market players. These companies are using organic and inorganic strategies for growth. For instance, in November 2018 Agilent technologies acquired ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. In August 2017, Dotz Nano teamed up with Sigma Aldrich to sell graphene quantum dots (GQD) through Sigma Aldrich’s online and printed catalogues. In January 2018, “Nanohybrids” launched PAtrace, a proprietary liposomal nanoparticle encasing a biocompatible optical absorber created to provide high-resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models.

Key Findings of the global gold nanoparticle market

  • Increase in usage in electronics manufacturing
  • Cell & phantom imaging is the fastest growing application of gold nanoparticles
  • The healthcare sector is the largest end-user of global gold nanoparticles market
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • INCREASE IN USAGE OF GOLD NANOPARTICLES IN ELECTRONICS MANUFACTURING
      • CELL & PHANTOM IMAGING IS THE FASTEST GROWING APPLICATION OF GOLD NANOPARTICLES
      • THE HEALTHCARE SECTOR IS THE LARGEST END-USER OF GLOBAL GOLD NANOPARTICLES
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • HIGHER DEMAND FROM DEVELOPING ECONOMIES
      • PREFERENCE FOR COMPACT ELECTRONIC DEVICES
      • DEVELOPMENT OF ULTRA-LIGHT MATERIALS
    • MARKET RESTRAINTS
      • BIOCOMPATIBILITY OF GOLD NANOPARTICLES
    • MARKET OPPORTUNITIES
      • TREATING A VARIETY OF DISEASES
      • USED IN THE BIOMEDICAL APPLICATIONS
    • MARKET CHALLENGES
      • VOLATILE GOLD PRICES
      • HIGH AVERAGE PRICES
  1. MARKET BY END USE
    • HEALTHCARE
    • ELECTRONICS
    • CATALYTIC ACTIVITY
    • OTHERS
  2. MARKET BY APPLICATION
    • IN-VIVO IMAGING
    • TARGETED DRUG DELIVERY
    • PROTON THERAPY
    • IN VITRO ASSAYS
    • CELL AND PHANTOM IMAGING
    • OTHERS
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • UNITED KINGDOM
      • FRANCE
      • ITALY
      • SPAIN
      • RUSSIA
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPANY PROFILES
    • AGILENT TECHNOLOGIES, INC.
    • BBI SOLUTIONS
    • CLINE SCIENTIFIC
    • CYTODIAGNOSTICS
    • MELIORUM TECHNOLOGIES
    • NANO COMPOSIX
    • SIGMA-ALDRICH (ACQUIRED BY MERCK)
    • TANAKA TECHNOLOGIES
    • NANOHYBRIDS
    • EXPEDEON

 

LIST OF TABLES

TABLE 1:      GLOBAL GOLD NANOPARTICLES MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 2:      GLOBAL GOLD NANOPARTICLES MARKET, BY END USE, 2019-2027, (IN $ MILLION)

TABLE 3:      GLOBAL GOLD NANOPARTICLES IN HEALTHCARE MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 4:      GLOBAL GOLD NANOPARTICLES IN ELECTRONICS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 5:      GLOBAL GOLD NANOPARTICLES IN CATALYTIC ACTIVITY MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 6:      GLOBAL OTHER MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 7:      GLOBAL GOLD NANOPARTICLES MARKET, BY APPLICATION, 2019-2027, (IN $ MILLION)

TABLE 8:      GLOBAL GOLD NANOPARTICLES BY IN-VIVO MARKET IMAGING, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 9:      GLOBAL GOLD NANOPARTICLES MARKET BY TARGETED DRUG DELIVERY MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 10:    GLOBAL GOLD NANOPARTICLE BY PROTON THERAPY MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 11:    GLOBAL GOLD NANOPARTICLE BY IN-VITRO ASSAY MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 12:    GLOBAL GOLD NANOPARTICLES BY CELL & PHANTOM IMAGING MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 13:    GLOBAL OTHER MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 14:    OPPORTUNITY MATRIX

TABLE 15:    VENDOR LANDSCAPE

TABLE 16:    GLOBAL GOLD NANOPARTICLES MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)

TABLE 17:    NORTH AMERICA GOLD NANOPARTICLES MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 18:    EUROPE GOLD NANOPARTICLES MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 19:    ASIA PACIFIC GOLD NANOPARTICLES MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 20:    REST OF WORLD GOLD NANOPARTICLES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1:    GLOBAL GOLD NANOPARTICLES MARKET, BY APPLICATION, 2018 & 2027 (IN %)

FIGURE 2:    GDP PER CAPITA OF DEVELOPING ECONOMIES IN $ (2013-2018)

FIGURE 3:    GLOBAL GOLD NANOPARTICLES MARKET, BY HEALTHCARE, 2019-2027 (IN $ MILLION)

FIGURE 4:    GLOBAL GOLD NANOPARTICLES MARKET, BY ELECTRONICS, 2019-2027 (IN $ MILLION)

FIGURE 5:    GLOBAL GOLD NANOPARTICLES MARKET, BY CATALYTIC ACTIVITY, 2019-2027 (IN $ MILLION)

FIGURE 6:    GLOBAL GOLD NANOPARTICLES MARKET, BY OTHER, 2019-2027 (IN $ MILLION)

FIGURE 7:    GLOBAL GOLD NANOPARTICLES MARKET, BY IN-VIVO IMAGING, 2019-2027 (IN $ MILLION)

FIGURE 8:    GLOBAL GOLD NANOPARTICLES MARKET, BY TARGETED DRUG DELIVERY, 2019-2027 (IN $ MILLION)

FIGURE 9:    GLOBAL GOLD NANOPARTICLES MARKET, BY PROTON THERAPY, 2019-2027 (IN $ MILLION)

FIGURE 10:  GLOBAL GOLD NANOPARTICLES MARKET, BY IN-VITRO ASSAYS, 2019-2027 (IN $ MILLION)

FIGURE 11:  GLOBAL GOLD NANOPARTICLES MARKET, BY CELL AND PHANTOM IMAGING, 2019-2027 (IN $ MILLION)

FIGURE 12:  GLOBAL GOLD NANOPARTICLES MARKET, BY OTHER, 2019-2027 (IN $ MILLION)

FIGURE 13:  PORTER’S FIVE FORCE ANALYSIS

FIGURE 14:  VALUE CHAIN ANALYSIS

FIGURE 15:  GLOBAL GOLD NANOPARTICLES MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 16:  UNITED STATES GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 17:  CANADA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 18:  GERMANY GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 19:  UNITED KINGDOM GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20:  NANOTECHNOLOGY PLAYERS IN FRANCE

FIGURE 21:  FRANCE GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 22:  ITALY GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 23:  SPAIN GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 24:  RUSSIA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 25:  REST OF EUROPE GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 26:  CHINA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 27:  INDIA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 28:  JAPAN GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 29:  SOUTH KOREA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 30:  AUSTRALIA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 31:  REST OF ASIA PACIFIC GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 32:  LATIN AMERICA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

FIGURE 33:  MIDDLE EAST & AFRICA GOLD NANOPARTICLES MARKET, 2019-2027 (IN $ MILLION)

  1. MARKET BY END USE
    • HEALTHCARE
    • ELECTRONICS
    • CATALYTIC ACTIVITY
    • OTHERS
  2. MARKET BY APPLICATION
    • IN-VIVO IMAGING
    • TARGETED DRUG DELIVERY
    • PROTON THERAPY
    • IN VITRO ASSAYS
    • CELL AND PHANTOM IMAGING
    • OTHERS
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • UNITED KINGDOM
      • FRANCE
      • ITALY
      • SPAIN
      • RUSSIA
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now